Design Therapeutics, Inc.

NasdaqGS:DSGN Stock Report

Market Cap: US$318.2m

Design Therapeutics Management

Management criteria checks 2/4

Design Therapeutics' CEO is Pratik Shah, appointed in Aug 2023, has a tenure of 1.25 years. total yearly compensation is $6.32M, comprised of 5.7% salary and 94.3% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $730.17K. The average tenure of the management team and the board of directors is 3.2 years and 4 years respectively.

Key information

Pratik Shah

Chief executive officer

US$6.3m

Total compensation

CEO salary percentage5.7%
CEO tenure1.3yrs
CEO ownership0.2%
Management average tenure3.2yrs
Board average tenure4yrs

Recent management updates

Recent updates

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Oct 04
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Jun 19
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Mar 15
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Nov 16
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Jun 06
Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Feb 09
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Oct 25
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Design Therapeutics GAAP EPS of -$0.27 misses by $0.02

Aug 08

We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate

Jul 02
We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Mar 18
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Dec 03
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Aug 18
Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Design Therapeutics expands board of directors

Jun 07

Design Therapeutics EPS misses by $0.24

May 10

CEO Compensation Analysis

How has Pratik Shah's remuneration changed compared to Design Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$48m

Jun 30 2024n/an/a

-US$51m

Mar 31 2024n/an/a

-US$59m

Dec 31 2023US$6mUS$361k

-US$67m

Sep 30 2023n/an/a

-US$72m

Jun 30 2023n/an/a

-US$74m

Mar 31 2023n/an/a

-US$69m

Dec 31 2022US$5mUS$338k

-US$63m

Sep 30 2022n/an/a

-US$57m

Jun 30 2022n/an/a

-US$51m

Mar 31 2022n/an/a

-US$43m

Dec 31 2021US$585kUS$310k

-US$36m

Sep 30 2021n/an/a

-US$28m

Jun 30 2021n/an/a

-US$19m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020US$400kUS$250k

-US$8m

Compensation vs Market: Pratik's total compensation ($USD6.32M) is above average for companies of similar size in the US market ($USD2.14M).

Compensation vs Earnings: Pratik's compensation has increased whilst the company is unprofitable.


CEO

Pratik Shah (54 yo)

1.3yrs

Tenure

US$6,317,780

Compensation

Dr. Pratik Shah, Ph D., is an Executive Chairperson at Design Therapeutics, Inc. since December 2017 and serves as its President, Chief Executive Officer and Principal Financial Officer since August 25, 20...


Leadership Team

NamePositionTenureCompensationOwnership
Pratik Shah
Co-Founder1.3yrsUS$6.32m0.23%
$ 730.2k
Sean Jeffries
Chief Operating Officer3.8yrsUS$1.28m1.44%
$ 4.6m
Aseem Ansari
Co-Founder & Scientific Advisorno datano data13.54%
$ 43.1m
Julie Burgess
Chief Accounting Officer3.2yrsno datano data
Mustapha Parekh
General Counselno datano datano data
Jae Kim
Consulting Chief Medical Officer2.8yrsno data0.0084%
$ 26.7k
Dawn Giangiulio
Controller4.6yrsno datano data

3.2yrs

Average Tenure

54yo

Average Age

Experienced Management: DSGN's management team is considered experienced (3.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Pratik Shah
Co-Founder6.9yrsUS$6.32m0.23%
$ 730.2k
Aseem Ansari
Co-Founder & Scientific Advisorno datano data13.54%
$ 43.1m
John Schmid
Independent Director4yrsUS$106.70k0.10%
$ 323.9k
Rodney Lappe
Independent Director5.3yrsUS$228.56k0.23%
$ 747.6k
Simeon George
Lead Independent Director4.8yrsUS$95.70k0%
$ 0
Deepa Prasad
Independent Director3.4yrsUS$94.20k0.042%
$ 133.8k
Heather Berger
Independent Director3.4yrsUS$94.20k0.0023%
$ 7.3k
Arsani William
Independent Director3.8yrsUS$104.20k0%
$ 0

4.0yrs

Average Tenure

49yo

Average Age

Experienced Board: DSGN's board of directors are considered experienced (4 years average tenure).